Pancreas adenocarcinoma: novel therapeutics.
Sign Up to like & getrecommendations! Published in 2017 at "Chinese clinical oncology"
DOI: 10.21037/cco.2017.06.14
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is the third highest cause of cancer-related deaths in the US, and is projected to be second only to non-small cell lung cancer (NSCLC) by the 2020s. Current therapies have a… read more here.
Keywords: pancreas adenocarcinoma; novel therapeutics; adenocarcinoma novel; cancer ... See more keywords
Preface: pancreas adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Chinese clinical oncology"
DOI: 10.21037/cco.2017.06.22
Abstract: Pancreas adenocarcinoma remains a very challenging malignancy with a rising incidence globally and in particular in western countries such as the United States, and China. read more here.
Keywords: pancreas adenocarcinoma; oncology; preface pancreas;